JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics
GlobeNewswire
The JAK inhibitor market is poised for robust growth in the coming years, driven by expanding applications across autoimmune..